226 related articles for article (PubMed ID: 23254690)
21. Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.
Stiles BM; Mirza F; Coppolino A; Port JL; Lee PC; Paul S; Altorki NK
Ann Thorac Surg; 2011 Aug; 92(2):491-6; discussion 496-8. PubMed ID: 21704291
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of cervical lymph node recurrence in patients with esophageal squamous cell carcinoma after esophagectomy with 2-field lymph node dissection.
Lee DH; Kim HR; Kim DK; Park SI; Kim YH
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):365-71. PubMed ID: 23422046
[TBL] [Abstract][Full Text] [Related]
23. Multimodality therapy including surgical resection and intraoperative electron radiotherapy for recurrent or advanced primary carcinoma of the urinary bladder or ureter.
Hallemeier CL; Karnes RJ; Pisansky TM; Davis BJ; Gunderson LL; Leibovich BC; Haddock MG; Choo R
Am J Clin Oncol; 2013 Dec; 36(6):596-600. PubMed ID: 22868244
[TBL] [Abstract][Full Text] [Related]
24. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
Malone JP; Stephens JA; Grecula JC; Rhoades CA; Ghaheri BA; Schuller DE
Head Neck; 2004 Jul; 26(7):561-72. PubMed ID: 15229898
[TBL] [Abstract][Full Text] [Related]
25. Treatment strategies in recurrent esophageal or junctional cancer.
Butter R; Lagarde SM; van Oijen MGH; Anderegg MCJ; Gisbertz SS; Meijer SL; Hulshof MCCM; Bergman JJGHM; van Berge Henegouwen MI; van Laarhoven HWM
Dis Esophagus; 2017 Sep; 30(9):1-9. PubMed ID: 28859371
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant concurrent chemoradiotherapy for locally advanced esophageal cancer in a single high-volume center.
Zanoni A; Verlato G; Giacopuzzi S; Weindelmayer J; Casella F; Pasini F; Zhao E; de Manzoni G
Ann Surg Oncol; 2013 Jun; 20(6):1993-9. PubMed ID: 23274533
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant intraoperative electron radiotherapy and external beam radiotherapy for locally advanced transitional cell carcinoma of the ureter.
Zhang Q; Fu S; Liu T; Peng L; Huang G; Lu JJ
Urol Oncol; 2009; 27(1):14-20. PubMed ID: 18367127
[TBL] [Abstract][Full Text] [Related]
28. Surgery and intraoperative electron radiotherapy in recurrent or metastatic oligotopic extrapelvic cancer: long-term outcome.
Calvo FA; González ME; González-San Segundo C; González-Bayón L; Lozano MA; Santos-Miranda JA; Alvarez E; García-Sabrido JL
Eur J Surg Oncol; 2012 Oct; 38(10):955-61. PubMed ID: 22819147
[TBL] [Abstract][Full Text] [Related]
29. Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer.
Krempien R; Roeder F; Oertel S; Roebel M; Weitz J; Hensley FW; Timke C; Funk A; Bischof M; Zabel-Du Bois A; Niethammer AG; Eble MJ; Buchler MW; Treiber M; Debus J
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1143-51. PubMed ID: 16979835
[TBL] [Abstract][Full Text] [Related]
30. Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials.
Oppedijk V; van der Gaast A; van Lanschot JJ; van Hagen P; van Os R; van Rij CM; van der Sangen MJ; Beukema JC; Rütten H; Spruit PH; Reinders JG; Richel DJ; van Berge Henegouwen MI; Hulshof MC
J Clin Oncol; 2014 Feb; 32(5):385-91. PubMed ID: 24419108
[TBL] [Abstract][Full Text] [Related]
31. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
Yu E; Dar R; Rodrigues GB; Stitt L; Videtic GM; Truong P; Tomiak A; Ash R; Brecevic E; Inculet R; Malthaner R; Vincent M; Craig I; Kocha W; Lefcoe M
Radiother Oncol; 2004 Nov; 73(2):141-8. PubMed ID: 15542160
[TBL] [Abstract][Full Text] [Related]
32. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
Gu Y; Swisher SG; Ajani JA; Correa AM; Hofstetter WL; Liao Z; Komaki RR; Rashid A; Hamilton SR; Wu TT
Cancer; 2006 Mar; 106(5):1017-25. PubMed ID: 16456809
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of external beam radiation therapy in patients treated with and without extended surgery and intraoperative electrons for locally recurrent rectal cancer: 16-year experience in a single institution.
Calvo FA; Sole CV; Alvarez de Sierra P; Gómez-Espí M; Blanco J; Lozano MA; Del Valle E; Rodriguez M; Muñoz-Calero A; Turégano F; Herranz R; Gonzalez-Bayon L; García-Sabrido JL
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):892-900. PubMed ID: 23845842
[TBL] [Abstract][Full Text] [Related]
34. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
35. Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.
Franko J; Voynov G; Goldman CD
Ann Thorac Surg; 2016 Mar; 101(3):1123-30. PubMed ID: 26652139
[TBL] [Abstract][Full Text] [Related]
36. [Impact of different extents of lymph node dissection on the survival in stage III esophageal cancer patients].
Zhang GQ; Han F; Sun W; Pang ZL; SiKanDaer AB; Wang HJ
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):858-62. PubMed ID: 19173833
[TBL] [Abstract][Full Text] [Related]
37. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
[TBL] [Abstract][Full Text] [Related]
38. Effect of neoadjuvant radiation dose on surgical and oncological outcome in locally advanced esophageal cancer.
Van Daele E; Ceelen W; Boterberg T; Varin O; Van Nieuwenhove Y; Van de Putte D; Geboes K; Pattyn P
Acta Chir Belg; 2015; 115():8-14. PubMed ID: 26021785
[TBL] [Abstract][Full Text] [Related]
39. Lymph node dissection after chemoradiation in esophageal cancer: a subgroup analysis of patients with and without pathological response.
Chao YK; Liu HP; Hsieh MJ; Wu YC; Liu YH; Yeh CH; Chang HK; Tseng CK
Ann Surg Oncol; 2012 Oct; 19(11):3500-5. PubMed ID: 22622470
[TBL] [Abstract][Full Text] [Related]
40. [Neoadjuvant chemoradiotherapy followed by combined thoracoscopic and laparoscopic esophagectomy in the treatment of locally advanced esophageal carcinoma].
Zhu CC; Chen BF; Kong M; Wang CG; Wang Z; Ma DH; Ye MH; Ye ZR
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Sep; 15(9):943-6. PubMed ID: 22990929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
